Gansu Longshenrongfa Pharmaceutical Industry CO.,LTD reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 584.8 million compared to CNY 271.66 million a year ago. Revenue was CNY 591.47 million compared to CNY 276.47 million a year ago.

Net income was CNY 32.19 million compared to CNY 8.39 million a year ago. Basic earnings per share from continuing operations was CNY 0.1061 compared to CNY 0.0277 a year ago. Diluted earnings per share from continuing operations was CNY 0.1061 compared to CNY 0.0277 a year ago.